Induction of anergy by antibody blockade of TCR in myelin oligodendrocyte glycoprotein-specific cells

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7259-7264

  Wasserman, Heather A ^a   Evavold, Brian D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTERFERON; BETA INTERFERON; CD69 ANTIGEN; CD86 ANTIGEN; EPSILON INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INTERFERON; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG; VACCINIA VACCINE; ANTIBODY; BLOCKING ANTIBODY; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; PEPTIDE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; GENE EXPRESSION; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS RECOMBINANT; ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; OPTIC NEURITIS; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES; ANTIBODIES, BLOCKING; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL PROLIFERATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN-ASSOCIATED GLYCOPROTEIN; OPTIC NEURITIS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 47249146866     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7259     Document Type: Article

References (36)

1. Labrecque, N., L. S. Whitfield, R. Obst, C. Waltzinger, C. Benoist, and D. Mathis. 2001. How much TCR does a T cell need? Immunity 15: 71-82.
2. Schodin, B. A., T. J. Tsomides, and D. M. Kranz. 1996. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Immunity 5: 137-146.
3. McNeil, L. K., and B. D. Evavold. 2003. TCR reserve: a novel principle of CD4 T cell activation by weak ligands. J. Immunol. 170: 1224-1230.
4. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273: 104-106.
5. Stephenson, R. P. 1956. A modification of receptor theory. Br. J. Pharmacol. 11: 379-393.
6. McNeil, L. K., and B. D. Evavold. 2002. Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation. Proc. Natl. Acad. Sci. USA 99: 4520-4525.
7. Kuchroo, V. K., A. C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L. B. Nicholson. 2002. T cell response in experimental autoimmune encephalo-myelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20: 101-123.
8. Martin, R., H. F. McFarland, and D. E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10: 153-187.
9. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1995. A myelin oligodendro-cyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V β expression of encephalitogenic T cells. Eur. J. Immunol. 25: 1951-1959.
10. Pagany, M, M. Jagodic, A. Schubart, D. Pham-Dinh, C. Bachelin, A. Baron van Evercooren, F. Lachapelle, T. Olsson, and C. Linington. 2003. Myelin oligodendrocyte glycoprotein is expressed in the peripheral nervous system of rodents and primates. Neurosci. Lett. 350: 165-168.
11. Derbinski, J., A. Schulte, B. Kyewski, and L. Klein. 2001. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2: 1032-1039.
12. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp Med. 197: 1073-1081.
13. Utsunomiya, Y., J. Bill, E. Palmer, K. GoIIob, Y. Takagaki, and O. Kanagawa. 1989. Analysis of a monoclonal rat antibody directed to the α-chain variable region (V α 3) of the mouse T cell antigen receptor. J. Immunol. 143:2602-2608.
14. Kuchroo, V. K., R. A. Sobel, J. C. Laning, C. A. Martin, E. Greenfield, M. E. Dorf. and M. B. Lees. 1992. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein: fine specificity and T cell receptor V β usage. J. Immunol. 14S-3776-3782.
15. Bettelli, E., D. Baeten, A. Jager, R. A. Sobel, and V. K. Kuchroo. 2006. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 116: 2393-2402.
16. Li, Y., Y. Huang, J. Lue, J. A. Quandt, R. Martin, and R. A. Mariuzza. 2005. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 24-2968-2979.
17. Hartemann-Heurtier, A., L. T. Mars, N. Bercovici, S. Desbois, C. Cambouris, E. Piaggio, J. Zappulla, A. Saoudi, and R. S. Liblau. 2004. An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes. J. Immunol. 172: 915-922.
18. Vergelli, M, B. Hemmer, M. Kalbus, A. B. Vogt, N. Ling, P. Conlon, J. E. Coligan, H. McFarland, and R. Martin. 1997. Modifications of peptide Iigands enhancing T cell responsiveness imply large numbers of stimulatory Iigands for autoreactive T cells. J. Immunol. 158: 3746-3752.
19. IIIes, Z., H. Waldner, J. Reddy, E. Bettelli, L. B. Nicholson, and V. K. Kuchroo. 2005. T cell tolerance induced by cross-reactive TCR Iigands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production. J. Immunol. 175: 1491-1497.
20. Alegre, M. L., L. J. Peterson, D. Xu, H. A. Sattar, D. R. Jeyarajah, K. Kowalkowski, J. R. Thistlethwaite, R. A. Zivin, L. Jolliffe, and J. A. Bluestone. 1994. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation 57: 1537-1543.
21. Chatenoud, L., E. Thervet, J. Primo, and J. F. Bach. 1994. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91: 123-127.
22. Weinshenker, B. G., B. Bass, S. Karlik, G. C. Ebers, and G. P. Rice. 1991. An open trial of OKT3 in patients with multiple sclerosis. Neurology 41: 1047-1052.
23. Matsumoto, Y., M. Tsuchida, H. Hanawa, and T. Abo. 1994. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor α β antibody. Immunology 81: 1-7.
24. Tran, G. T., N. Carter, X. Y. He, T. S. Spicer, K. M. Plain, M. Nicolls, B. M. Hall, and S. J. Hodgkinson. 2001. Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)l cells that is augmented by IL-4. Int. Immunol. 13: 1109-1120.
25. Boussiotis, V. A., J. G. Gribben, G. J. Freeman, and L. M. Nadler. 1994. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr. Opin. Immunol. 6: 797-807.
26. Allen, S. D., S. V. Rawale, C. C. Whitacre, and P. T. Kaumaya. 2005. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade. J. Pept. Res. 65: 591-604.
27. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, K. S. Hathcock, G. Laszlo, A. J. McKnight, J. Kim, L. Du, D. B. Lombard, el al. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262: 907-909.
28. Jenkins, M. K., D. Mueller, R. H. Schwartz, S. Carding, K. Bottomley, M. J. Stadecker, K. B. Urdahl, and S. D. Norton. 1991. Induction and maintenance of anergy in mature T cells. Adv. Exp. Med. Biol. 292: 167-176.
29. Friedman, A., and H. L. Weiner. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91: 6688-6692.
30. Chen, Y., J. Inobe, V. K. Kuchroo, J. L. Baron, C. A. Janeway, Jr., and H. L. Weiner. 1996. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Nail. Acad. Sci. USA 93: 388-391.
31. Korb, L. C, S. Mirshahidi, K. Ramyar, A. A. Sadighi Akha, and S. Sadegh-Nasseri. 1999. Induction of T cell anergy by low numbers of agonist Iigands. J. Immunol. 162: 6401-6409.
32. Ryan, K. R., L. K. McNeil, C. Dao, P. E. Jensen, and B. D. Evavold. 2004. Modification of peptide interaction with MHC creates TCR partial agonists. Cell. Immunol. 227: 70-78.
33. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363: 156-159.
34. Evavold, B. D., J. Sloan-Lancxster, and P. M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide Iigands. Immunol. Today 14: 602-609.
35. Ford, M. L., and B. D. Evavold. 2003. Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55.7. Immunol. 171: 1247-1254.
36. Margot, C. D., M. L. Ford, and B. D. Evavold. 2005. Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151. J. Immunol. 174: 3352-3358.